Infant deaths during a trial of a medicine that protects against respiratory syncytial virus were caused by unrelated factors ...

A WHO official this week said repatriation is one of multiple factors fueling rises in Pakistan and Afghanistan.

The drug was 88% effective against the need for medical attention among those in their second respiratory virus season.

Some Alberta doctors are calling on the provincial government to make an injection designed to protect newborns from severe ...

Widespread distribution of nirsevimab to infants with respiratory syncytial virus infection raised concerns about potential ...

Infants will be able to receive a free immunisation to protect them against serious illness from respiratory syncytial virus (RSV), under a new $16.6 million NSW Government RSV prevention program to ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV) -- which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)-;which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

They also may have implications for when the RSV monoclonal antibody, Nirsevimab, should be administered to newborns. Similar ...